Literature DB >> 28740640

Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease: still far from the truth?

Mabrouk Bahloul1, Rania Ammar1, Abir Bouattour1, Samar Bellil1, Hedi Chelly1, Anis Chaari1, Mounir Bouaziz1.   

Abstract

Entities:  

Year:  2017        PMID： 28740640      PMCID： PMC5506132          DOI： 10.21037/jtd.2017.05.41

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  8 in total

1.  Acetazolamide use in severe COPD exacerbations requiring invasive mechanical ventilation: impact on duration of mechanical ventilation.

Authors:  Mabrouk Bahloul; Kamilia Chtara; Hedi Chelly; Kais Regaieg; Anis Chaari; Mounir Bouaziz
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.

Authors:  Christophe Faisy; Amel Mokline; Olivier Sanchez; Jean-Marc Tadié; Jean-Yves Fagon
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

3.  Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.

Authors:  Cemalettin Alp; Şeyda Özsoy; Nurdan Alcan Alp; Deryanur Erdem; Mehmet Serdar Gültekin; Ömer İrfan Küfrevioğlu; Murat Şentürk; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2011-12-22       Impact factor: 5.051

4.  Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial.

Authors:  G Rialp Cervera; J M Raurich Puigdevall; I Morán Chorro; M C Martín Delgado; G Heras la Calle; A Mas Serra; I Vallverdú Perapoch
Journal:  Pulm Pharmacol Ther       Date:  2017-03-07       Impact factor: 3.410

5.  Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Authors:  Christophe Faisy; Ferhat Meziani; Benjamin Planquette; Marc Clavel; Arnaud Gacouin; Caroline Bornstain; Francis Schneider; Alexandre Duguet; Sébastien Gibot; Nicolas Lerolle; Jean-Damien Ricard; Olivier Sanchez; Michel Djibre; Jean-Louis Ricome; Antoine Rabbat; Nicholas Heming; Saïk Urien; Maxime Esvan; Sandrine Katsahian
Journal:  JAMA       Date:  2016-02-02       Impact factor: 56.272

6.  Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients.

Authors:  Nicholas Heming; Christophe Faisy; Saïk Urien
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

7.  Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation.

Authors:  Mabrouk Bahloul; Anis Chaari; Ahmed Tounsi; Olfa Turki; Kamilia Chtara; Chokri Ben Hamida; Hatem Ghadhoune; Hassen Dammak; Hedi Chelly; Mounir Bouaziz
Journal:  Int J Crit Illn Inj Sci       Date:  2015 Jan-Mar

8.  Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients.

Authors:  Nicholas Heming; Saïk Urien; Virginie Fulda; Ferhat Meziani; Arnaud Gacouin; Marc Clavel; Benjamin Planquette; Christophe Faisy
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.